Scientific Background
A high-performance GH-axis trio combining Tesamorelin—a potent GHRH analog—with
CJC-1295 No DAC and Ipamorelin. This blend is frequently chosen for metabolic, bodycomposition, and cellular-recovery research.
Mechanism of Action (Informational Only)

• Tesamorelin: strong GHRH receptor activation
• CJC-1295: stabilizes GH pulsation
• Ipamorelin: selective ghrelin agonist
• Combined influence on IGF-1 and repair pathways

Potential Functional Benefits

• Supports body-composition research
• Interest in metabolic and visceral-fat–related studies
• May enhance recovery or repair responses
• Popular in performance-optimization models

Vial Contents

• Tesamorelin 6mg
• CJC-1295 No DAC 3mg
• Ipamorelin 3mg

Notes
For research and educational purposes only.